Óû§Ãû: ÃÜÂë: ÑéÖ¤Âë:    ×¢²á | Íü¼ÇÃÜÂë?
Ê×Ò³|ÌýÁ¦×ÊÔ´|ÿÈÕÌýÁ¦|ÍøÂçµç̨|ÔÚÏߴʵä|ÌýÁ¦ÂÛ̳|ÏÂÔØÆµµÀ|²¿Âä¼ÒÔ°|ÔÚÏß±³µ¥´Ê|Ë«ÓïÔĶÁ|ÔÚÏßÌýд|ÆÕÌØÍøÐ£

¿Æ¼¼:Ó¢¹úµÄ»ùÒò¼ôµ¶½«¿ª·¢ÐÂÒ©

2015-02-03    À´Ô´:chinadaily    ¡¾´ó ÖРС¡¿      ÃÀ¹úÍâ½Ì ÔÚÏß¿ÚÓïÅàѵ

¿Æ¼¼:Ó¢¹úµÄ»ùÒò¼ôµ¶½«¿ª·¢ÐÂÒ©

British pharmaceutical giant AstraZeneca has announced a research programme to develop a new generation of medicines to treat the genetic causes of many debilitating diseases, such as diabetes, heart disease and many cancers.
Ó¢¹úÖÆÒ©¾ÞÍ·°¢Ë¹Àû¿µÖÆÒ©ÈÕǰÐû²¼Ò»ÏîÑо¿¼Æ»®£¬¿ª·¢ÐÂÒ»´úÒ©ÎÖÎÁÆÐí¶àÒòÒÅ´«ÒòËØÒýÆðµÄʹÈËË¥ÈõµÄ¼²²¡£¬ÀýÈçÌÇÄò²¡¡¢ÐÄÔಡºÍ²»ÉÙ°©Ö¢¡£
 
AstraZeneca said it plans to make use of so-called CRISPR genome-editing technology for key therapeutic areas including oncology. The technology enables researchers to “edit” the genes of certain cells relatively quickly and accurately.
°¢Ë¹Àû¿µ³Æ£¬Æä¼Æ»®ÊÇÔÚ°üÀ¨Ö×ÁöѧµÄÖØÒªÖÎÁÆÁìÓòÀûÓñ»³Æ×÷CRISPRµÄ“»ùÒò¼ôµ¶”¼¼Êõ¡£“»ùÒò¼ôµ¶”¼¼ÊõʹµÃÑо¿ÈËÔ±¿ÉÒÔÏà¶Ô¿ì¶ø×¼µØ“±à¼­”һЩϸ°ûµÄ»ùÒò¡£


Àý¾ä£º
Some companies are using gene-editing techniques to change the plant's existing DNA rather than insert foreign genes.
һЩ¹«Ë¾ÕýʹÓÓ»ùÒò¼ôµ¶”¼¼ÊõÀ´¸Ä±äÖ²ÎïÏÖÔÚµÄDNA£¬¶ø²»ÊDzåÈëÍâÀ´»ùÒò¡£


¶¥Ò»ÏÂ
(0)
0%
²ÈÒ»ÏÂ
(0)
0%
ÊÖ»úÉÏÆÕÌØ m.putclub.com ÊÖ»úÉÏÆÕÌØ
[ÔðÈα༭£ºTina]
------·Ö¸ôÏß----------------------------
·¢±íÆÀÂÛ ²é¿´ËùÓÐÆÀÂÛ
Çë×Ô¾õ×ñÊØ»¥ÁªÍøÕþ²ß·¨¹æ£¬ÑϽû·¢²¼É«Çé¡¢±©Á¦¡¢·´¶¯µÄÑÔÂÛ¡£
ÆÀ¼Û:
񡀂:
Óû§Ãû: ÃÜÂë: ÑéÖ¤Âë:
  • ÍÆ¼öÎÄÕÂ
  • ×ÊÁÏÏÂÔØ
  • ½²×ù¼Òô
ÆÕÌØÓ¢ÓïÊÖ»úÍøÕ¾
ÓÃÊÖ»úä¯ÀÀÆ÷ÊäÈëm.putclub.com½øÈëÆÕÌØÊÖ»úÍøÕ¾Ñ§Ï°
²é¿´¸ü¶àÊÖ»úѧϰAPP>>